Acadia Pharmaceuticals (ACAD) Technical (Analysis) Reports Acadia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Acadia Pharmaceuticals (ACAD)
Technical Analysis Report for NASDAQ stock ACAD Acadia Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ACAD Acadia Pharmaceuticals then click here. or read Experts views on Acadia Pharmaceuticals or Forecast & share price targets of Acadia Pharmaceuticals
Acadia Pharmaceuticals Opened at 24.04 and Closed at: 23.56, which is 0.42% of previous session's close. It moved within a range of 23.37 and 24.04
The session was a Bearish session with an average volume of 2355800, which is 49.72% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 4 days back on mid term averages
Support for tomorrow is 23.13 and resistance for tomorrow is 23.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 23.27, 22.99 resistance for tomorrow's hourly charts is 23.94, 24.33
10 Day SMA for Acadia Pharmaceuticals (ACAD) is 25.17 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Acadia Pharmaceuticals (ACAD) is 25.91 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Acadia Pharmaceuticals (ACAD) is 26.35 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 24.33 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Acadia Pharmaceuticals is 23.08 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Acadia Pharmaceuticals is at 25.91 and 200 DMA is at 23.08, while 50 DMA and 100 DMA are at 26.35 and 24.33 respectively
Acadia Pharmaceuticals (ACAD) moving average of 20 SMA is at 25.91 and 20 EMA is at 25.55
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 23.56 | 25.91 | 25.55 |
| 05 Thu Feb | 23.46 | 26.08 | 25.76 |
| 04 Wed Feb | 24.23 | 26.28 | 26 |
| 03 Tue Feb | 24.75 | 26.42 | 26.19 |
| 02 Mon Feb | 26.14 | 26.49 | 26.34 |
| 30 Fri Jan | 25.13 | 26.49 | 26.36 |
Acadia Pharmaceuticals (ACAD) moving average of 50 SMA is at 26.35 and 50 EMA is at 25.66
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 23.56 | 26.35 | 25.66 |
| 05 Thu Feb | 23.46 | 26.36 | 25.75 |
| 04 Wed Feb | 24.23 | 26.36 | 25.84 |
| 03 Tue Feb | 24.75 | 26.33 | 25.91 |
| 02 Mon Feb | 26.14 | 26.3 | 25.96 |
| 30 Fri Jan | 25.13 | 26.25 | 25.95 |
Acadia Pharmaceuticals (ACAD) moving average of 100 SMA is at 24.33 and 100 EMA is at 24.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 23.56 | 24.33 | 24.84 |
| 05 Thu Feb | 23.46 | 24.34 | 24.87 |
| 04 Wed Feb | 24.23 | 24.35 | 24.9 |
| 03 Tue Feb | 24.75 | 24.34 | 24.91 |
| 02 Mon Feb | 26.14 | 24.34 | 24.91 |
| 30 Fri Jan | 25.13 | 24.32 | 24.89 |
Acadia Pharmaceuticals (ACAD) moving average of 200 SMA is at 23.08 and 200 EMA is at 23.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 23.56 | 23.08 | 23.27 |
| 05 Thu Feb | 23.46 | 23.04 | 23.27 |
| 04 Wed Feb | 24.23 | 23 | 23.27 |
| 03 Tue Feb | 24.75 | 22.95 | 23.26 |
| 02 Mon Feb | 26.14 | 22.9 | 23.24 |
| 30 Fri Jan | 25.13 | 22.84 | 23.21 |
Xtl Biopharmaceuticals has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 71.72% more returns!
Trinity Biotech has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Trinity Biotech, about 21.61% more returns!
Scholar Rock has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Scholar Rock, about 24.92% more returns!
Scynexis Inc has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Scynexis Inc, about 25.45% more returns!
Acadia Pharmaceuticals has performed better than Phio Pharmaceuticals in short term. Holding Acadia Pharmaceuticals could be a better choice for now!
Puma Biotechnology has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Puma Biotechnology, about 25.77% more returns!
Neogen Corporation has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Neogen Corporation, about 24.29% more returns!
Acadia Pharmaceuticals has performed better than Endra Life in short term. Holding Acadia Pharmaceuticals could be a better choice for now!
Moleculin Biotech has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Moleculin Biotech, about 21.69% more returns!
Lakeland Industries has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Lakeland Industries, about 20.81% more returns!
Acadia Pharmaceuticals has performed better than Accuray Incorporated in short term. Holding Acadia Pharmaceuticals could be a better choice for now!
Atricure Inc has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Atricure Inc, about 1.53% more returns!
Aurinia Pharmaceuticals has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 7.33% more returns!
Corcept Therapeutics has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 20.96% more returns!
Catalyst Pharmaceuticals has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 19.59% more returns!
Cue Biopharma has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Cue Biopharma, about 0.91% more returns!
Dynavax Technologies has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Dynavax Technologies, about 12.6% more returns!
Eyegate Pharmaceuticals has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 11.82% more returns!
Genprex Inc has performed better than Acadia Pharmaceuticals in short term. You could have earned much better returns by investing in Genprex Inc, about 12.02% more returns!
Acadia Pharmaceuticals Technical analysis of indicators
Price action analysis of Acadia Pharmaceuticals (ACAD) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Acadia Pharmaceuticals in short term and the sell signal is strong.
Acadia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.87 and Acadia Pharmaceuticals ACAD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Acadia Pharmaceuticals ACAD stock. Volume based technical analysis of Acadia Pharmaceuticals ACAD stock is negative.
Acadia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ACAD Acadia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ACAD Experts View which covers a lot of information including buying and selling signals
ACAD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Acadia Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Acadia Pharmaceuticals (ACAD) Technical (Analysis) Reports Acadia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


